Health & Science

Home Health & Science

Trump Aide Faints On Stage During Republican Gala

1
Photo via Pixabay images

An adviser to President-elect Trump’s campaign, Alex Bruesewitz, passed out and collapsed as he was speaking onstage during a New York Young Republican Club gala Sunday night.

Alex Bruesewitz, 27, was introducing incoming White House senior aide Dan Scavino inside a venue in Manhattan when he began stumbling over his words and fainted, video on social media shows.

Watch:

Several people quickly rushed to help after his collapse. It was not immediately clear what caused him to faint.

“I talked to our friend Alex Bruesewitz and you know what he said to me? He goes ‘Did I at least look cool?’ I said Alex, you used gravity like I’ve seen nobody use gravity before in their lives,” Kassam said. “But he’s recuperating back there, so give him a big cheer so he’ll hear you.”

Trump also said following the collapse that he believes Bruesewitz will be fine, according to the New York Post.

“I know that Alex is going to be fine because he’s a tough son of a gun,” Trump said. “There’s no doubt about that. So I want to say hello to Alex, because he’s a very special guy.”

Bruesewitz is the CEO of consultancy firm X Strategies LLC, which states its mission to help elect “America First” candidates. Its website says he is “a prominent political consultant and strategist known for his unwavering support of President Donald Trump and the America First agenda.”

Before his collapse, Bruesewitz commended the New York Republican Club for backing Trump’s campaign. He also gave shout-outs to several supporters of the incoming president who were at the event, including former Florida congressman Matt Gaetz, who recently resigned from his U.S. House seat.

Trump Urged To Intervene After Vance Relative Reportedly Denied Organ Transplant Over Covid Vax

3

President Donald Trump is facing pressure to use his executive power to block hospitals from denying organ transplants for people not vaccinated against COVID-19 after reports emerged that Vice President JD Vance’s 12-year-old relative was reportedly denied a heart transplant over her COVID-19 vaccination status

In a letter to President Trump, Rep. Michael Rulli (R-Ohio) alongside Rep. Erin Houchin (R-Ind.) called on Trump to take action. Rep. Rulli said he was partially moved to act after hearing about Vance’s relative.

The letter, signed by Rulli, Houchin and five other House Republicans, cited Trump’s executive orders ending COVID-19 vaccine mandates in schools and reinstating military service members who were discharged for not getting the vaccine. (RELATED: Trump Reinstates Service Members Discharged Over COVID-19 Vaccine In Executive Order Flurry)

“Over the past week, it has come to light that multiple desperate Americans have been denied life-saving organ transplants due to their COVID-19 vaccination status,” the letter said. “This outrageous denial of care has affected some of our most vulnerable citizens – including a child from Indiana and a veteran from Ohio.”

Houchin told Fox News, “Patients – especially children – should never be turned away from care due to government-imposed mandates. This effort urges President Trump to take action to ensure no hospital or transplant center can discriminate against patients based on their decision to decline the COVID-19 vaccine.”

“President Trump has done such a great job recently on executive orders,” Rulli told Fox News Digital in an interview. “And I am asking President Trump if he sees this, to please do an executive order… because you could save someone’s life today.”

“The timing is everything. If we don’t get this done, people’s lives could be at risk.”

Read:

The girl’s mother, Jeneen Deal, told the Daily Mail that giving her daughter the vaccine would violate the family’s religious beliefs.

Vance said in comments to the Daily Mail that he would try to help.

“I guess it’s been circulating on social media, but I was made aware of a couple days ago, and we’re trying to dig in and trying to help, obviously, as much as possible,” he said.

Trump Signs Executive Order To Tie US Drug Prices To Global Lows

0

On Monday morning, President Donald Trump signed a sweeping executive order aimed at dramatically lowering prescription drug prices in the United States. At the center of the order is a “most favored nation” (MFN) pricing policy, which mandates that the U.S. pay no more for medications than the lowest price paid by any other country. Trump claims the initiative could cut drug prices by 30% to 80%, potentially saving American taxpayers trillions of dollars.

The MFN policy revives a proposal from Trump’s first term and targets the longstanding disparity in drug costs between the U.S. and other nations. The order also directs the Department of Health and Human Services to begin broad drug price negotiations, while introducing measures to combat anti-competitive practices, expand drug imports, and scrutinize the role of pharmacy benefit managers (PBMs).

The New York Post reports:

“What’s been happening is, we’ve been subsidizing other countries throughout the world,” Trump explained at a White House signing ceremony, calling Monday’s action one of his “most important orders.”

“Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%, he added. “Big Pharma will either abide by this principle voluntarily or we’ll use the power of the federal government to ensure that we are paying the same price.”

The policy is a revival of Trump’s signature “most favored nation” drive from his first term, with a new push to get foreign countries to take on more of the research and development (R&D) costs that experts say America has disproportionately shouldered.

“Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” the president previously promised on Truth Social Sunday. “The United States will save TRILLIONS OF DOLLARS.”

The announcement triggered immediate market reaction, with shares of pharmaceutical giants like AstraZeneca and GSK seeing declines. Industry leaders have warned the policy could stifle innovation and competition, arguing it may disincentivize research and development.

Although the Biden administration previously took steps to lower drug prices through the Inflation Reduction Act, Trump’s executive order takes a more aggressive approach by linking U.S. prices directly to global lows.

However, the new policy is expected to face significant legal and logistical hurdles, particularly due to the complexity of the U.S. drug pricing system and the opaque nature of international pricing mechanisms.

White House Addresses Trump Health After Viral Photos Spark Speculation

By The White House - https://www.flickr.com/photos/202101414@N05/54581054338/, Public Domain,

White House press secretary Karoline Leavitt addressed concerns over President Donald Trump’s health during a briefing on Thursday after photographs of his hand appearing bruised and his ankles appearing swollen went viral.

“I know that many in the media have been speculating about bruising on the president’s hand, and also swelling in the president’s legs. So in the effort of transparency, the president wanted me to share a note from his physician with all of you today,” began Leavitt before reading from the note:

In recent weeks, President Trump noted mild swelling in his lower legs. In keeping with routine medical care and out of an abundance of caution, this concern was thoroughly evaluated by the White House Medical Unit. The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70.

Importantly, there was no evidence of deep vein thrombosis or arterial disease. Laboratory testing included a complete blood count, comprehensive metabolic panel, coagulation profile, D-dimer, B-type, natriotic, peptide, and cardiac biomarkers. All results were within normal limits. An echocardiogram was also performed, and confirmed normal cardiac structure and function. No signs of heart failure, renal impairment, or systemic illness were identified.

Additionally, recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking, and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy, and the president remains in excellent health.

“Which I think all of you witness on a daily basis here,” added Leavitt. “So the president wanted me to share that note with all of you. I’m happy to take further questions on it. We will provide the memorandum from the president’s physician to all of you, as we always do.

Watch:

Minnesota Republicans Propose Bill Classifying “Trump Derangement Syndrome” as Mental Illness

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons

Minnesota Senate Republicans have introduced a bill to define “Trump Derangement Syndrome” (TDS) as a form of mental illness. Senate Bill 2589, which is set to be formally introduced and read on March 17, 2025, igniting significant debate due to the novelty of a politically charged term in the medical lexicon.

The bill, sponsored by Republican State Senators Eric Lucero, Steve Drazkowski, Nathan Wesenberg, Justin Eichorn, and Glenn Gruenhagen, seeks to amend the state’s definition of mental illness by adding a specific reference to TDS. According to the text of the bill, mental illness would include “Trump Derangement Syndrome” or an organic disorder of the brain that significantly impairs an individual’s ability to function in daily life.

The bill describes TDS as “the acute onset of paranoia in otherwise normal persons that is in reaction to the policies and presidencies of President Donald J. Trump.” According to the proposal, individuals affected by TDS exhibit symptoms of paranoia and an inability to separate legitimate political disagreements from perceived personal or psychological pathology in Trump’s behavior.

The bill further characterizes TDS as leading to “Trump-induced general hysteria,” where individuals may struggle to distinguish between policy differences and a supposed mental condition in the former president’s actions. These symptoms, the bill argues, can severely impair personal relationships, work, and other aspects of daily living.

The bill has already been logged into the Minnesota legislature’s official website, but it is set to undergo formal introduction on March 17, 2025. Its introduction has garnered widespread attention, with reactions split along party lines.

Supporters of the bill argue that it is a legitimate attempt to address a condition that they believe affects a significant portion of the population, particularly those who strongly opposed former President Trump. By naming and defining TDS, they argue, the bill opens a discussion about how political figures can profoundly affect the psychological well-being of individuals, especially during times of heightened political polarization.

Article Published With The Permission of American Liberty News

Biden Cancer Diagnosis Spurs White House Coverup Accusations

Photo via Gage Skidmore Flickr

The news of former President Joe Biden’s cancer diagnosis has sent shockwaves across America.

Biden’s team announced Sunday that he’d been diagnosed with an aggressive form of prostate cancer that had already metastasized to the bone, adding his family would examine suitable treatment for the “management” of the disease.

The shocking news comes amid heightened scrutiny surrounding the Bidens potential coverup of former President Biden’s mental and physical decline while in office.

On Monday, Rep. Ronny Jackson (R-TX) accused the Biden White House of a “political cover up” and lashed out at Biden’s then-White House doctor, though not by name, and accused the physician of having failed to deliver “world class care” to Biden and engaging in a “cover up.”

President Donald Trump posted a message to his Truth Social app on Sunday from himself and First Lady Melania Trump expressing their sympathy and well-wishes for Biden, after it was announced that the former president is battling very serious prostate cancer.

Trump Jr. likewise initially offered an expression of sympathy, by way of reposting a message on his account at X.

Sharing a screenshot that included the message “Politics aside, we wish [President Biden] a speedy recover,” Trump Jr. commented “Agreed 100%.”

In another post three hours later which also included a screenshot, Trump Jr. had a more critical take on the tragic news.

His screenshot showed a message on the nature of Biden’s particular cancer, and calling into question the timeline of when Democrats, or at least the White House, knew about it.

“What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer or is this yet another coverup???” he said, with a sarcastic jab at former First Lady Jill Biden.

The hosts of Fox & Friends were in disbelief Monday morning at Joe Biden’s advanced cancer diagnosis despite the “fantastic medical care” that he receives as a former president.

“These are the types of things you look for when you get older,” Kilmeade added. “And very curious to see and somewhat discouraging to think someone could have this type of medical attention and have this get to this point.”

Co-host Charles Hurt added: “Especially because it’s a fairly advanced form so much so that it has metastasized to a bone. And you would think that would give you a lot more time to catch it.”

Later in the show, the curvy couch welcomed Fox News medical expert Dr. Marc Siegel, who echoed their surprise.

“Really, really surprising that it’s this advanced at the time of diagnosis,” he said. “Now, you can miss prostate cancer but most of the time regular screening picks it up. A sitting president I would expect to have advanced screening should not be subject to debate what kind of screening.”

Noem Hospitalized After Allergic Reaction; Biohazard Lab Visit Under Scrutiny

1
Photo via Pixabay images

On the evening of Tuesday, June 17, 2025, Homeland Security Secretary Kristi Noem was rushed by ambulance to a Washington, D.C. hospital after suffering what officials described as an allergic reaction. According to a statement from the Department of Homeland Security (DHS), Noem was treated “out of an abundance of caution” and remains in stable condition.

The medical emergency drew swift attention — not only because of Noem’s high-profile cabinet role, but also due to the timing. Just one day earlier, she had visited the Integrated Research Facility at Fort Detrick, Maryland, a high-security federal lab that handles some of the world’s most dangerous pathogens, including Ebola and SARS-CoV-2. She was accompanied on the tour by Health and Human Services Secretary Robert F. Kennedy Jr. and Senator Rand Paul (R-Ky.).

The Fort Detrick facility has been under scrutiny in recent months. In April, it was temporarily shut down following safety concerns involving possible tampering with personal protective equipment. Though the lab has since resumed operations, the incident left lingering questions about oversight and internal protocols.

While the proximity of Noem’s hospital visit to her tour of the lab has sparked speculation, DHS downplayed any connection. Officials stressed there is no indication the allergic reaction had anything to do with the biohazard site, and current evidence points to coincidence, not causation.

Still, the lack of detail surrounding Noem’s condition — and the decision to visit to a facility recently flagged for a safety lapse — has fueled speculation. Noem has not issued a public statement since the incident, though an official told the Associated Press that the secretary is “alert and recovering.”

Security around the hospital was visibly heightened following Noem’s arrival, with multiple eyewitnesses reporting Secret Service personnel stationed at emergency entrances and perimeter points.

As of now, Noem remains under medical supervision, and DHS has indicated she will resume duties once cleared by her doctors. The department has not disclosed whether additional tests are being conducted to rule out environmental or chemical triggers.

What We Know — and Don’t

The facts are straightforward, even if the full picture isn’t: Secretary Noem had an acute medical event. She had just visited a facility known for housing lethal biological agents. There’s no official link between the two events. But in an era when institutional trust runs thin and information gaps invite conspiracy theories, the sequence of events is likely to keep this story alive longer than a typical health scare.

For now, DHS says Noem is recovering and expected to make a full recovery. But until more details emerge — from medical professionals or Noem herself — the story will likely remain a focus of intense public interest.

READ NEXT: Musk Confronts Key Ally — Forces Bombshell Admission

Supreme Court Greenlights Trump NIH Cuts Targeting DEI, COVID Research

The U.S. Supreme Court on Thursday cleared the way for the Trump administration to move forward with nearly $800 million in cuts to National Institutes of Health grants.

The decision allows the administration to withhold funds that had been frozen by a lower court — grants largely tied to diversity, equity, and inclusion (DEI) initiatives, as well as studies focused on minority health, LGBTQ+ issues, vaccine hesitancy, COVID-19, and similar public health topics.

A federal trial court in Massachusetts had previously ruled in June that many of the cuts were “arbitrary and discriminatory,” ordering the temporary restoration of those grants.

But the Supreme Court, acting through its emergency — or so-called “shadow” — docket, overrode that ruling in a narrow 5–4 decision.

Chief Justice John Roberts sided with the liberal bloc in dissent. Justice Ketanji Brown Jackson issued a sharply worded dissent of her own, criticizing the court’s reliance on the emergency process and the brevity of the majority’s explanation.

As SCOTUSBlog reports, the court — also by a 5–4 margin — left in place another part of the lower court’s ruling affecting internal NIH guidance documents outlining the agency’s policy priorities:

Justice Amy Coney Barrett provided the key vote on each issue. She joined Justices Clarence Thomas, Samuel Alito, Neil Gorsuch, and Brett Kavanaugh in voting to allow NIH to terminate the grants, but she joined Chief Justice John Roberts and Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson in voting to leave the lower court’s ruling on the guidance documents in place.

Jackson had sharp words for her colleagues, describing the ruling as “Calvinball jurisprudence” – a reference to the Calvin and Hobbes cartoon – “with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins.”

NIH ended hundreds of grants it linked to DEI-related studies in response to a series of executive orders issued by President Donald Trump after his inauguration in January. The first order, titled “Ending Radical and Wasteful Government DEI Programs and Preferencing,” instructed the director of the Office of Management and Budget, assisted by the attorney general and the director of the Office of Personnel Management, to work to end “discriminatory programs, including illegal DEI” programs in the federal government. It was followed by two other executive orders, titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” and “Ending Illegal Discrimination and Restoring Merit-Based Opportunity.”

Two separate groups of plaintiffs went to federal court in Massachusetts to challenge the termination of the grants. One group is made up of 16 states whose public universities receive funding from NIH, while the other consists of the American Public Health Association, individual researchers, a union, and a reproductive health advocacy group. They contended that the termination of the grants violated both the Constitution and the Administrative Procedure Act, the federal law governing administrative agencies.

The administration argues the research in question lacks scientific rigor and was driven more by ideology than merit. Officials also say the cuts are consistent with their broader push to eliminate DEI-related spending across federal agencies.

Democrat-led states and advocacy groups claim the funding loss could have “incalculable” consequences for underserved communities.

This case fits a broader pattern: The court has recently upheld rollbacks on DEI-based spending in areas like teacher training. Critics say the use of the emergency docket limits public transparency and bypasses full hearings. Supporters say it’s a legitimate tool to keep activist courts in check.

Legal challenges are still moving through the lower courts.

In the meantime, universities, NIH personnel, and left-leaning advocacy groups are mobilizing in protest, warning of long-term damage to public health research and institutional equity efforts.

READ NEXT: Police Swarm Former Trump Ally’s Mansion